MANAGEMENT OF OROPHARYNGEAL CANDIDIASIS

In France, the incidence of cancer is estimated at 270,000 new cases per year. The availability of new treatments and the improvement in treatment regimens contribute to an increase in therapeutic effectiveness. However, anticancer treatments induce several adverse events that may affect treatment regimens, particularly when they compromise nutritional status. The most common adverse events localized in the oral cavity are mucositis and infections, including oropharyngeal candidiasis (OPC) regardless of cancer localization.  OPC and mucositis are closely related and often associated. They both induce pain, taste impairment, reduction in saliva flow, and xerostomia  making chewing and swallowing painful...

To read the full research report, click below to view the PDF:

Management of Oropharyngeal candidiasis

Share on